Panel Upholds $17M Attorney Fee Award, Cites Bad-Faith Patent Litigation by Drug Companies (Law.com)

Panel Upholds $17M Attorney Fee Award, Cites Bad-Faith Patent Litigation by Drug Companies (Law.com)
A three-judge Federal Circuit panel upheld an attorney fee award of nearly $17 million on Monday because of baseless filings and bad-faith patent litigation by two drug companies. Takeda Chemical Industries sued two generic drug companies — Mylan Laboratories and Alphapharm Pty. Ltd. — for patent infringement, and was granted an award of attorney fees under a section of the law that permits …